KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 92 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $35,589,000 | +40.0% | 474,675 | +40.6% | 0.03% | +75.0% |
| Q2 2015 | $25,423,000 | +94.7% | 337,593 | +29.7% | 0.02% | +100.0% |
| Q1 2015 | $13,055,000 | +657.7% | 260,361 | +423.7% | 0.01% | +700.0% |
| Q4 2014 | $1,723,000 | +8.7% | 49,713 | +2.6% | 0.00% | 0.0% |
| Q3 2014 | $1,585,000 | +278.3% | 48,430 | +342.0% | 0.00% | – |
| Q2 2014 | $419,000 | -83.9% | 10,958 | -83.2% | 0.00% | -100.0% |
| Q1 2014 | $2,597,000 | +45.7% | 65,345 | +36.8% | 0.00% | +100.0% |
| Q4 2013 | $1,782,000 | +109.9% | 47,752 | +156.2% | 0.00% | 0.0% |
| Q3 2013 | $849,000 | – | 18,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |